Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Decitabine Combined With NK Cell Infusion in the Treatment of Malignant Tumors

NCT05143125 is registered in ClinicalTrials.gov with Shenzhen University General Hospital as lead sponsor.

NCT NCT05143125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05143125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Decitabine Combined With NK Cell Infusion in the Treatment of Malignant Tumors
Lead sponsor
Shenzhen University General Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 5, 2021
Completion date
February 29, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignancy